We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+3.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$90.3B
AUM Growth
+$7.19B
(+8.7%)
Cap. Flow
+$4.56B
Cap. Flow
% of AUM
5.05%
Top 10 Holdings %
Top 10 Hldgs %
12.91%
Holding
4,527
New
567
Increased
2,145
Reduced
1,207
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$526M |
| 2 |
US Bancorp
USB
|
+$301M |
| 3 |
Pultegroup
PHM
|
+$217M |
| 4 |
BATS
Bats Global Markets, Inc.
BATS
|
+$145M |
| 5 |
Charter Communications
CHTR
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARG
Airgas Inc
ARG
|
+$477M |
| 2 |
Pfizer
PFE
|
+$305M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$294M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$275M |
| 5 |
XIV
VelocityShares Daily Inverse VIX Short Term ETN
XIV
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.61% |
| 2 | Technology | 10.97% |
| 3 | Healthcare | 10.51% |
| 4 | Consumer Discretionary | 7.19% |
| 5 | Industrials | 6.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
2751
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.05M | ﹤0.01% |
26,943
+1,828
| +7% | +$65.7K |
|
2752
Federal Signal
FSS
$6.82B
| $1.04M | ﹤0.01% |
81,037
+33,077
| +69% | +$435K |
|
|
NIHD
2753
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $1.04M | ﹤0.01% |
327,889
-2,870,778
| -90% | -$12M |
|
|
BKMU
2754
DELISTED
Bank Mutual Corp
BKMU
| $1.04M | ﹤0.01% |
135,498
+46,655
| +53% | +$366K |
|
|
ZLTQ
2755
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $1.04M | ﹤0.01% |
38,100
+27,728
| +267% | +$780K |
|
2756
Medifast
MED
$107M
| $1.04M | ﹤0.01% |
31,172
+23,159
| +289% | +$747K |
|
|
GHY
2757
PGIM Global High Yield Fund
GHY
$476M
| $1.04M | ﹤0.01% |
69,000
| – | – |
|
|
SODA
2758
DELISTED
SodaStream International Ltd
SODA
| $1.03M | ﹤0.01% |
48,470
-146,076
| -75% | -$2.6M |
|
2759
Enpro
NPO
$6.26B
| $1.03M | ﹤0.01% |
23,251
-28,956
| -55% | -$1.5M |
|
2760
Rush Enterprises Class A
RUSHA
$6.34B
| $1.03M | ﹤0.01% |
107,770
+73,053
| +210% | +$647K |
|
|
VG
2761
DELISTED
Vonage Holdings Corporation
VG
| $1.03M | ﹤0.01% |
168,708
-150,450
| -47% | -$710K |
|
|
SSRG
2762
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| $1.03M | ﹤0.01% |
+78,388
| New | +$947K |
|
|
ASRT
2763
DELISTED
Assertio
ASRT
| $1.03M | ﹤0.01% |
873
-162
| -16% | -$177K |
|
2764
CareTrust REIT
CTRE
$10B
| $1.03M | ﹤0.01% |
74,569
+5,313
| +8% | +$70.2K |
|
2765
Enviri
NVRI
$624M
| $1.03M | ﹤0.01% |
154,962
-6,314
| -4% | -$41.1K |
|
|
CFNL
2766
DELISTED
Cardinal Financial Corp
CFNL
| $1.03M | ﹤0.01% |
46,851
+10,939
| +30% | +$235K |
|
2767
DHT Holdings
DHT
$2.99B
| $1.03M | ﹤0.01% |
203,776
+51,998
| +34% | +$288K |
|
|
FOLD
2768
DELISTED
Amicus Therapeutics
FOLD
| $1.03M | ﹤0.01% |
187,811
+30,541
| +19% | +$214K |
|
2769
PLDT
PHI
$4.31B
| $1.03M | ﹤0.01% |
23,000
+8,000
| +53% | +$319K |
|
|
BKS
2770
DELISTED
Barnes & Noble
BKS
| $1.03M | ﹤0.01% |
90,294
-42,010
| -32% | -$487K |
|
|
LHCG
2771
DELISTED
LHC Group LLC
LHCG
| $1.02M | ﹤0.01% |
23,683
+11,232
| +90% | +$458K |
|
2772
Stride
LRN
$4.16B
| $1.02M | ﹤0.01% |
81,841
+32,796
| +67% | +$371K |
|
2773
Delek US
DK
$3.98B
| $1.02M | ﹤0.01% |
77,238
+6,648
| +9% | +$94.6K |
|
2774
TFS Financial
TFSL
$5.11B
| $1.02M | ﹤0.01% |
59,328
+28,798
| +94% | +$513K |
|
2775
Inovio Pharmaceuticals
INO
$85.6M
| $1.02M | ﹤0.01% |
9,195
+8
| +0.1% | +$972 |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2016 Portfolio in Review
As of Q2 2016, Credit Suisse held 4,527 positions worth $90.3B, up 8.7% from $83.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Credit Suisse deployed $4.56B of net new capital in Q2 2016, opening 567 new positions and adding to 2,145 existing holdings. Its largest new stake was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $305M trimmed.
- Credit Suisse's largest Q2 2016 buy was Bats Global Markets, Inc.: 5,676,642 shares worth $146M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $526M increase.
- Credit Suisse's biggest Q2 2016 reduction was Pfizer, cutting an estimated $305M.
- Credit Suisse fully exited Airgas Inc in Q2 2016, selling an estimated $477M.
- Credit Suisse's ten largest holdings make up 13% of its $90.3B portfolio in Q2 2016.
- Credit Suisse opened 567 new positions and closed 344 in Q2 2016.
- Credit Suisse's portfolio value rose 8.7% quarter-over-quarter to $90.3B.
Based on Credit Suisse's 13F filing for Q2 2016, filed 11 Aug 2016.